Revenue Recognition (Tables)

6 Months Ended

Jun. 30, 2020

The following tables present the Company’s revenue disaggregated by geographical region for the three and six months ended June 30, 2020 and, 2019, respectively. Domestic refers to revenue from customers based in the United States, and substantially all foreign revenue is derived from dermatology procedures equipment sales to the Company’s international master distributor for physicians based primarily in Asia and recurring revenue from our distributor in Korea.

	Three Months Ended June 30, 2020
	Dermatology Recurring Procedures		Dermatology Procedures Equipment		TOTAL
Domestic	$	2,670	$	125	$	2,795
Foreign		126		1,109		1,235
Total	$	2,796	$	1,234	$	4,030

	Six Months Ended June 30, 2020
	Dermatology Recurring Procedures		Dermatology Procedures Equipment		TOTAL
Domestic	$	8,267	$	440	$	8,707
Foreign		230		1,823		2,053
Total	$	8,497	$	2,263	$	10,760

	Three Months Ended June 30, 2019
	Dermatology Recurring Procedures		Dermatology Procedures Equipment		TOTAL
Domestic	$	5,839	$	378	$	6,217
Foreign		-		1,508		1,508
Total	$	5,839	$	1,886	$	7,725

	Six Months Ended June 30, 2019
	Dermatology Recurring Procedures		Dermatology Procedures Equipment		TOTAL
Domestic	$	11,151	$	702	$	11,853
Foreign		-		3,355		3,355
Total	$	11,151	$	4,057	$	15,208

Future Undiscounted Fixed Treatment Code Payments from International Recurring Revenue Customers

The following table summarizes the Company’s expected future undiscounted fixed treatment code payments from international recurring revenue customers as of June 30,

Remaining 2020	$	244
2021		474
2022		474
2023		405
2024		178
Thereafter		-
Total	$	1,775